146 related articles for article (PubMed ID: 15789441)
1. Interstitial lung disease in patients with ataxia-telangiectasia.
Schroeder SA; Swift M; Sandoval C; Langston C
Pediatr Pulmonol; 2005 Jun; 39(6):537-43. PubMed ID: 15789441
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.
Tillie-Leblond I; Wislez M; Valeyre D; Crestani B; Rabbat A; Israel-Biet D; Humbert M; Couderc LJ; Wallaert B; Cadranel J
Thorax; 2008 Jan; 63(1):53-9. PubMed ID: 17557770
[TBL] [Abstract][Full Text] [Related]
3. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine cell hyperplasia as an unusual form of interstitial lung disease.
Reyes LJ; Majó J; Perich D; Morell F
Respir Med; 2007 Aug; 101(8):1840-3. PubMed ID: 17586309
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between cigarette smoking and some types of idiopathic interstitial pneumonias].
Gasior G; Pierzchała W; Ograbek-Król M
Wiad Lek; 2008; 61(1-3):48-52. PubMed ID: 18717043
[TBL] [Abstract][Full Text] [Related]
8. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
9. Pediatric interstitial lung disease.
Vijayasekaran D; Giridhar S; Gowrishankar NC; Nedunchelian K; Senguttuvan M
Indian Pediatr; 2006 Oct; 43(10):899-903. PubMed ID: 17079834
[TBL] [Abstract][Full Text] [Related]
10. Lung disease in Niemann-Pick disease.
Guillemot N; Troadec C; de Villemeur TB; Clément A; Fauroux B
Pediatr Pulmonol; 2007 Dec; 42(12):1207-14. PubMed ID: 17969000
[TBL] [Abstract][Full Text] [Related]
11. Role of bronchoalveolar lavage in the initial diagnosis of smoking-related interstitial lung diseases.
Domagala-Kulawik J; Maskey-Warzechowska M; Krenke R; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():243-51. PubMed ID: 19218648
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of fibrosing diffuse parenchymal lung disease.
Morgenthau AS; Padilla ML
Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
[TBL] [Abstract][Full Text] [Related]
13. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
[TBL] [Abstract][Full Text] [Related]
14. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
15. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-induced interstitial lung disease.
Wagner SA; Mehta AC; Laber DA
Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study.
Sigurdsson MI; Isaksson HJ; Gudmundsson G; Gudbjartsson T
Ann Thorac Surg; 2009 Jul; 88(1):227-32. PubMed ID: 19559230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
